Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Tandem autologous-haploidentical transplantation is a feasible and effective program for... Bone Marrow Transplantation (2018) 53:366–370 https://doi.org/10.1038/s41409-017-0032-1 CORRESPONDENCE Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma 1 1 2 2 2 1 ● ● ● ● ● ● Jacopo Mariotti Stefania Bramanti Raynier Devillier Sabine Furst Jean El Cheikh Barbara Sarina 2 2 2 1 2 ● ● ● ● ● Angela Granata Catherine Faucher Samia Harbi Lucio Morabito Pierre Jean Weiller 3,4,5 6 7 1,8 1,9 ● ● ● ● ● Christian Chabannon Jamel Mokart Rossana Mineri Carmelo Carlo-Stella Armando Santoro 2,4,5 1 Didier Blaise Luca Castagna Received: 25 May 2017 / Revised: 17 September 2017 / Accepted: 18 September 2017 / Published online: 21 December 2017 © Macmillan Publishers Limited, part of Springer Nature 2018 Introduction autologous transplant for high-risk patients according to the SFGM score, showing a 5-year PFS and OS of 46 and 57%. High dose chemotherapy (HDCT) followed by autologous A sequential program was previously shown to be fea- stem cell transplantation in chemorefractory Hodgkin lym- sible and effective for resistant HL with a 2-year event free phoma (HL) patients resulted in a disappointing long-term survival (EFS) of approximately 50% [7]. We have found progression-free survival (PFS) lower than 30–40% http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bone Marrow Transplantation Springer Journals
Loading next page...
 
/lp/springer_journal/tandem-autologous-haploidentical-transplantation-is-a-feasible-and-IYtKpagJJZ
Publisher
Nature Publishing Group UK
Copyright
Copyright © 2017 by The Author(s) 2017, under exclusive licence to Macmillan Publishers Limited, part of Springer Nature
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Cell Biology; Public Health; Hematology; Stem Cells
ISSN
0268-3369
eISSN
1476-5365
D.O.I.
10.1038/s41409-017-0032-1
Publisher site
See Article on Publisher Site

Abstract

Bone Marrow Transplantation (2018) 53:366–370 https://doi.org/10.1038/s41409-017-0032-1 CORRESPONDENCE Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma 1 1 2 2 2 1 ● ● ● ● ● ● Jacopo Mariotti Stefania Bramanti Raynier Devillier Sabine Furst Jean El Cheikh Barbara Sarina 2 2 2 1 2 ● ● ● ● ● Angela Granata Catherine Faucher Samia Harbi Lucio Morabito Pierre Jean Weiller 3,4,5 6 7 1,8 1,9 ● ● ● ● ● Christian Chabannon Jamel Mokart Rossana Mineri Carmelo Carlo-Stella Armando Santoro 2,4,5 1 Didier Blaise Luca Castagna Received: 25 May 2017 / Revised: 17 September 2017 / Accepted: 18 September 2017 / Published online: 21 December 2017 © Macmillan Publishers Limited, part of Springer Nature 2018 Introduction autologous transplant for high-risk patients according to the SFGM score, showing a 5-year PFS and OS of 46 and 57%. High dose chemotherapy (HDCT) followed by autologous A sequential program was previously shown to be fea- stem cell transplantation in chemorefractory Hodgkin lym- sible and effective for resistant HL with a 2-year event free phoma (HL) patients resulted in a disappointing long-term survival (EFS) of approximately 50% [7]. We have found progression-free survival (PFS) lower than 30–40%

Journal

Bone Marrow TransplantationSpringer Journals

Published: Dec 21, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial